Oncomed Pharma (OMED) Posts Q1 Loss of 47c/Share

Oncomed Pharma (NASDAQ: OMED) reported Q1 EPS of ($0.47), which may not compare with the analyst estimate of ($0.13).

For earnings history and earnings-related data on Oncomed Pharma (OMED) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Brinker Int'l (EAT) PT Raised to $285 at UBS Following 'Impressive' Q4 Outperformance
• Azitra, Inc. (AZTR) Tops Q2 EPS by 54c